183 related articles for article (PubMed ID: 2590267)
21. Comparable morning versus evening administration of once-daily mometasone furoate dry powder inhaler.
Zetterström O; Dahl R; Lindqvist A; Olsson P
Respir Med; 2008 Oct; 102(10):1406-11. PubMed ID: 18640826
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of a new sustained-release formulation of theophylline sodium glycerinate in healthy subjects with a new asymmetric dosage regimen.
Wang P; Qi M; Zhong D; Fang L
Biomed Chromatogr; 2003 Jan; 17(1):58-61. PubMed ID: 12583008
[TBL] [Abstract][Full Text] [Related]
23. Individualization of theophylline dosage: a Bayesian method evaluated in patients with once-daily dosing.
Martz W; Oellerich M; Schnabel D; Sybrecht GW
Ther Drug Monit; 1991 Sep; 13(5):420-4. PubMed ID: 1957334
[TBL] [Abstract][Full Text] [Related]
24. Night-time pharmacokinetics of once a day theophylline: a steady state comparison of three preparations.
Karttunen P; Tukiainen H; Nykänen S; Saano V
Int J Clin Pharmacol Ther Toxicol; 1985 Mar; 23(3):161-5. PubMed ID: 3997302
[TBL] [Abstract][Full Text] [Related]
25. [Comparison of serum concentrations of once and twice daily administration of ultra-retard theophylline in school children with bronchial asthma].
Liebke C; Niggemann B; Wahn U
Pneumologie; 1996 Nov; 50(11):752-5. PubMed ID: 9082442
[TBL] [Abstract][Full Text] [Related]
26. Nocturnal asthma: effect of a once per evening dose of sustained release theophylline.
Neuenkirchen H; Wilkens JH; Oellerich M; Sybrecht GW
Eur J Respir Dis; 1985 Mar; 66(3):196-204. PubMed ID: 3884358
[TBL] [Abstract][Full Text] [Related]
27. Clinical relevance of theophylline chronokinetics for asthmatic children.
Smolensky MH; Scott PH; McGovern JP
Prog Clin Biol Res; 1987; 227B():259-70. PubMed ID: 3628336
[TBL] [Abstract][Full Text] [Related]
28. Time-dependent disposition of tacrolimus and its effect on endothelin-1 in liver allograft recipients.
Min DI; Chen HY; Lee MK; Ashton K; Martin MF
Pharmacotherapy; 1997; 17(3):457-63. PubMed ID: 9165550
[TBL] [Abstract][Full Text] [Related]
29. The effect of dosing time on the pharmacokinetics and pharmacodynamics of a 'once-a-day' sustained release theophylline preparation.
Lamont H; Pauwels R; Van der Straeten M
Br J Clin Pharmacol; 1987 Dec; 24(6):735-42. PubMed ID: 3440095
[TBL] [Abstract][Full Text] [Related]
30. Biopharmaceutic characteristics of a new extended-release theophylline formulation (Uni-Dur).
Oosterhuis B; Brannan MD; Groen H; Peeters PA; Hempenius J; Radwanski E; Nomeir AA; Affrime MB; Jonkman JH
Ann Allergy Asthma Immunol; 1995 Aug; 75(2):157-61. PubMed ID: 7648380
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of sustained release theophylline given at three different evening intake times in addition to a baseline medication.
Siebert B; Kunkel G; Borner K; Staudinger HW; Steinijans VW
Eur Respir J; 1990 Feb; 3(2):176-81. PubMed ID: 2178965
[TBL] [Abstract][Full Text] [Related]
32. [Pharmacokinetics of theophylline in sustained-release formulation in young asthmatics].
Witschital K; Fuchs WS; Heese U; von Nieciecki A; Laicher A
Arzneimittelforschung; 1998 May; 48(5A):593-6. PubMed ID: 9676351
[TBL] [Abstract][Full Text] [Related]
33. [Comparative study of plasma levels of 2 delayed-action theophyllines: Theostat 200 and Theodur 200, after a single evening dose].
Philip-Joet F; Bruguerolle B; Lagier F; Arnaud A
Rev Pneumol Clin; 1986; 42(6):279-83. PubMed ID: 3563255
[TBL] [Abstract][Full Text] [Related]
34. [Euphylong in patients with chronic obstructive airway diseases].
Kublik A; von Wichert P
Pneumologie; 1991 Nov; 45 Suppl 4():858-62. PubMed ID: 1812480
[TBL] [Abstract][Full Text] [Related]
35. [Efficacy of a theophylline retard preparation administered at 3 different intake times additionally to basic medication].
Siebert B; Kunkel G; Borner K; Staudinger HW; Böhm A; Steinijans VW
Pneumologie; 1991 Nov; 45 Suppl 4():842-7. PubMed ID: 1812477
[TBL] [Abstract][Full Text] [Related]
36. Theophylline levels after single daily and divided dosing of a once-a-day theophylline preparation in asthmatic children.
Boner AL; Sette L; Vallone G; Plebani M; Messori A
Ann Allergy; 1989 Feb; 62(2):149-53. PubMed ID: 2919803
[TBL] [Abstract][Full Text] [Related]
37. Effect of ozagrel (OKY-046), a thromboxane synthetase inhibitor, on theophylline pharmacokinetics in asthmatic patients.
Kawakatsu K; Kino T; Yasuba H; Kawaguchi H; Tsubata R; Satake N; Oshima S
Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):158-63. PubMed ID: 2338368
[TBL] [Abstract][Full Text] [Related]
38. [Dose titration with Euphylong following prior determination of serum concentration in the steady state].
Schnabel D; von Treufels S; Oellerich M; Böttger HC; Sybrecht GW
Pneumologie; 1990 Feb; 44 Suppl 1():287-8. PubMed ID: 2367392
[TBL] [Abstract][Full Text] [Related]
39. Comparison of morning versus evening dosing with a new once-daily oral theophylline formulation.
Rivington RN; Calcutt L; Child S; MacLeod JP; Hodder RV; Stewart JH
Am J Med; 1985 Dec; 79(6A):67-72. PubMed ID: 4083303
[TBL] [Abstract][Full Text] [Related]
40. [The pharmacokinetic study of a daily dose of theophylline].
Arenoso HJ; Dall LL; Soutric JL; Martin J
Medicina (B Aires); 1992; 52(6):555-9. PubMed ID: 1340905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
